Adhesive properties and inflammatory potential of citrullinated myelin basic protein peptide 45-89

Lali V Shanshiashvili1, Irina V Kalandadze, Jeremy J Ramsden

  • 1Ilia State University, 3/5 Cholokhashvili Str, 0162 Tbilisi, Georgia. lali_shanshiashvili@iliauni.edu.ge

Insights

Citrullinated myelin basic protein (MBP) peptides are less stable on lipid membranes and trigger microglial cells to release nitric oxide, causing oligodendrocyte apoptosis. This suggests a self-perpetuating cycle of damage in myelin disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Deimination of myelin basic protein (MBP) reduces its positive charge, disrupting myelin membrane assembly and increasing susceptibility to proteolysis.
  • This process releases immunogenic deiminated peptides, potentially contributing to neuroinflammatory conditions.

Purpose of the Study:

  • To investigate the interaction of citrullinated and phosphorylated MBP peptides (45-89) with myelin lipids.
  • To determine the effects of these peptides on oligodendrocyte and microglial cells, focusing on apoptosis and inflammatory responses.

Main Methods:

  • Optical waveguide lightmode spectrometry was used to analyze peptide-lipid interactions.
  • Mixed oligodendrocyte/microglial cell cultures were exposed to MBP peptides to assess apoptosis, nitric oxide production, and signaling pathways (iNOS, NF-kB, IkB).

Main Results:

  • Citrullinated MBP 45-89 peptides showed reduced adsorption to lipid membranes compared to phosphorylated peptides.
  • Exposure to citrullinated MBP 45-89 peptides induced apoptosis in oligodendrocytes via the mitochondrial pathway.
  • These peptides stimulated microglial nitric oxide secretion and involved the NF-kB signaling pathway.

Conclusions:

  • Citrullinated MBP peptides exhibit altered membrane interactions and can induce oligodendrocyte apoptosis.
  • Activated microglia release nitric oxide, potentially creating a feedback loop that exacerbates oligodendrocyte death.
  • These findings shed light on the pathogenic mechanisms involving deiminated MBP in demyelinating diseases.